Results 121 to 130 of about 5,141 (164)

Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma. [PDF]

Liver Cancer
Kudo M.
europepmc   +1 more source

The raising and westward expansion of central Tibet. [PDF]

Natl Sci Rev
Zhao C, Ding L, Xiong Z, Spicer RA, Cai F, He S, Wang C, Ding W, Li J, Wang H, Yin Z, Xu X, Xie J, Yue Y, Zeng D, Kaveh-Firouz A.   +15 more
europepmc   +1 more source

INDETERMINATE DOMAIN-DELLA protein interactions orchestrate gibberellin-mediated cell elongation in wheat and barley

Sokolowska P, Jost M, Buss W, Ford B, Chandler PM, Spielmeyer W, Phillips A, Huttly AK, Tarkowská D, Alarcón-Reverte R, Clark SJ, Pearce S, Hedden P, Thomas SG.   +13 more
europepmc   +1 more source

Balancing anticancer therapy efficacy and safety in advanced hepatocellular carcinoma: a case report. [PDF]

J Gastrointest Oncol
Mourad M, Al Mahmasani L, Abbas N, Sainamthip P, Freile B, Zayed A, Alsuwailem R, Khatib O, Sinno S, Sabatin F, Shia J, Kreidieh F, Paroder V, Alam S, Shamseddine A, Abou-Alfa GK.   +15 more
europepmc   +1 more source

Establishing reproductive seasons for the conservation of the critically endangered Kashmir red deer Cervus Hanglu. [PDF]

Sci Rep
Srivastava T, Hameed J, Kumar V, Segu H, Narayan S, John M, Vasudevan K, Umapathy G.   +7 more
europepmc   +1 more source

Risk factors associated with high altitude sickness among travelers: A case control study in Himalaya district of Nepal. [PDF]

PLOS Glob Public Health
Poudel S, Wagle L, Ghale M, Aryal TP, Pokharel S, Adhikari B.   +5 more
europepmc   +1 more source

The first complete mitochondrial genome of Loimia arborea (Polychaeta: Terebellidae) and phylogenetic analysis. [PDF]

Mitochondrial DNA B Resour
Xu XH, Luo CY, Mu Y.
europepmc   +1 more source

Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma. [PDF]

Ther Adv Med Oncol
Liao W, Xu H, Hutton D, Wu Q, Yang Y, Feng M, Lei W, Bai L, Li J, Li Q.   +9 more
europepmc   +1 more source

Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment. [PDF]

Drugs Real World Outcomes
Fujiwara Y, Kuroda H, Abe T, Kakisaka K, Nakaya I, Ito A, Watanabe T, Yusa K, Nagasawa T, Sato H, Suzuki A, Endo K, Yoshida Y, Oikawa T, Sawara K, Miyasaka A, Matsumoto T.   +16 more
europepmc   +1 more source

Digital Himalaya

, 2013
openaire   +2 more sources